Stockscreener 앱 받기
35.64
1.57%
-0.57
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
What drives Vaxcyte Inc. stock priceExtraordinary profit generation - jammulinksnews.com
What analysts say about Vaxcyte Inc. stockRapidly growing investment returns - Autocar Professional
Is Vaxcyte Inc. a good long term investmentOverwhelming financial success - Autocar Professional
Vaxcyte Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN
Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com
Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize
What makes Vaxcyte Inc. stock price move sharplyBreakout Momentum Stocks - beatles.ru
Why Vaxcyte Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - Newser
How Vaxcyte Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
Teacher Retirement System of Texas Sells 2,779 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - Insider Monkey
(PCVX) Trading Advice - news.stocktradersdaily.com
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
Vaxcyte (PCVX): Riding Passive Fund Winds to FDA Catalysts – A Tactical Play with Strategic Upside - AInvest
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Value Index - MarketScreener
Vaxcyte (PCVX): Riding Clinical Catalysts Against a Stormy Regulatory Tide - AInvest
Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks
How To Trade (PCVX) - news.stocktradersdaily.com
Cantor Fitzgerald Estimates Vaxcyte FY2026 Earnings - Defense World
Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Vaxcyte: Sentiment Is Pushing The Shares Down (NASDAQ:PCVX) - Seeking Alpha
Cantor Fitzgerald maintains Overweight on Vaxcyte shares By Investing.com - Investing.com Canada
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of “Buy” by Analysts - Defense World
(PCVX) Long Term Investment Analysis - news.stocktradersdaily.com
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM) - Defense World
Vaxcyte (VCYT) Jumps Over 4.5%: Is This Biotech Eyeing a Return Towards Its $121 High? - Daily Chhattisgarh News
Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors - DirectorsTalk Interviews
James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University
Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
0.87%
0.17%
자본화:
|
볼륨(24시간):